Skip to main content
[Preprint]. 2024 Nov 4:2024.11.04.621904. [Version 1] doi: 10.1101/2024.11.04.621904

Figure 4: Patient response to JCV and BKV VP1 (100–108).

Figure 4:

Flow cytometry data of live CD8+ T cells stained with HLA-A2:BK VP1 (100–108) and HLA-A2:JV VP1 (100–108) at 1:50 tetramer dilution with an HLA-A2 positive JCV antibody negative healthy donor on the left and an HLA-A2 confirmed PML survivor on the right.